TGFB1 and cancer: Specific therapy targeting this cytokine in advanced cancer patients has shown promising results in preclinical and clinical studies, using TGF-β inhibitors, specifically ligand traps, antisense oligonucleotides, receptor kinase inhibitors, and peptide aptamers.